Trial Profile
Phase II Trial of Induction Therapy With Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation in Patients With AL Amyloidosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Sep 2020
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone (Primary) ; Dexamethasone (Primary) ; Melphalan
- Indications Amyloidosis
- Focus Therapeutic Use
- 04 Sep 2020 Status changed from active, no longer recruiting to completed.
- 04 Dec 2018 Results of the long-term follow up analysis, presented at the 60th Annual Meeting and Exposition of the American Society of Hematology
- 17 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.